Search for content, post, videos

Scandinavian Biopharma enters into agreement with USAMRAA

Björn Sjöstrand
Scandinavian Biopharma has entered into an agreement with the United States Army Medical Research Acquisition Activity (USAMRAA) to support the production and development of the vaccine, with the long-term goal of preventing bacterial diarrhoea in war fighters. In April this year, SBH announced t
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.